Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AbbVie Inc. Director's Dealing 2017

Jun 15, 2017

29755_dirs_2017-06-15_4fdd1099-aa06-44dd-b1dc-5407da9e0d5e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2017-06-14

Reporting Person: ALBAN CARLOS (EVP, Commercial Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-06-14 Common stock, $0.01 par value M 45800 $24.2082 Acquired 160545 Direct
2017-06-14 Common stock, $0.01 par value S 45800 $70.00 Disposed 114745 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-06-14 Option (right to buy) $24.2082 M 45800 Disposed 2021-02-17 Common stock (45800) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common stock, $0.01 par value 40442 Indirect

Footnotes

F1: Held in the Maria Christina Alban 2007 Declaration of Trust. The reporting person's spouse is trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.